Table 1

Contents of Bcl-xl and Bcl-xs mRNA in different types of endometrial tissue and correlation with pathological parameters of the endometrial carcinoma

Classification

Bcl-xl mRNA expression

Bcl-xs mRNA expression

χ ± S

P value

χ ± S

P value

Normal endometrium

0.35 ± 4.37

0.93 ± 3.05

Simple hyperplasia

0.38 ± 3.25

0.13

0.89 ± 2.00

0.12

Atypical hyperplasia

0.37 ± 3.93

0.38

0.68 ± 0.10

0.00

Endometrial carcinoma

0.75 ± 0.13

0.00

0.49 ± 0.14

0.00

Degree of Pathological Differentiation

Well-differentiated

0.85 ± 7.23

0.52 ± 0.14

Moderately-differentiated

0.70 ± 7.60

F = 5.33

0.45 ± 0.16

F = 0.40

Poorly-differentiated

0.70 ± 1.44

P = 0.02

0.48 ± 7.57

P = 0.68

Clinical Staging

Stage I

0.74 ± 0.15

0.55 ± 7.67

Stage II

0.79 ± 0.10

F = 0.57

0.41 ± 2.83

F = 30.87

Stage III

0.82 ± 0.15

P = 0.58

0.21 ± 7.77

P = 0.00

Lymph Node Metastasis

No

0.82 ± 0.16

F = 2.31

0.51 ± 9.16

F = 0.64

Yes

0.79 ± 0.10

P = 0.73

0.25 ± 6.70

P = 0.00

Depth of Myometrial Invasion

0

0.82 ± 7.26

0.58 ± 7.07

≤ 1/2

0.76 ± 0.11

F = 3.22

0.45 ± 0.16

F = 1.73

> 1/2

0.64 ± 4.73

P = 0.07

0.45 ± 6.03

P = 0.22

Ma et al. Journal of Experimental & Clinical Cancer Research 2010 29:14   doi:10.1186/1756-9966-29-14